Completed PHASE4 INTERVENTIONAL 2-arm NCT01316367

Effectiveness of PRECEDE Model for Health Education on Changes and Level of Control in Patients With Type 2 Diabetes Mellitus

Effectiveness of PRECEDE Model for Health Education on Cardiovascular Risk Reduction in Patients With Type 2 Diabetes Mellitus

Sponsor: Hospital Carlos III, Madrid

Conditions Cardiovascular Risk Factor Type 2 Diabetes Mellitus

Interventions CHPE PRECEDE HPE model

Updated 4 times since 2017 Last updated: Mar 15, 2011 Started: Feb 28, 2003 Primary completion: Feb 28, 2005 Completion: Mar 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Cardiovascular Risk Factor and Type 2 Diabetes Mellitus and is currently completed. Hospital Carlos III, Madrid leads this study, which shows 4 recorded versions since 2003 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2017 — Jan 2021 [monthly]

Completed PHASE4

First recorded

Feb 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Carlos III, Madrid

Data source: Hospital Carlos III, Madrid

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain